ADHD & Pilot Certification
Last updated: 2026-03-01
Quick Facts
- ADHD diagnosis alone is NOT automatically disqualifying
- ALL stimulant medications (Adderall, Ritalin, Vyvanse, Concerta) are disqualifying — no exceptions
- Non-stimulant ADHD medications (Strattera, Intuniv) are also currently disqualifying
- Must be off medication for at least 90 days before neuropsychological evaluation
- Comprehensive neuropsych testing is required to demonstrate safe cognitive function
- Pilots diagnosed as children who have been off medication for years generally have a smoother process
- FAA policy on ADHD has not been significantly updated since the early 2000s
- Legislative efforts to modernize ADHD policy are ongoing but no changes have been enacted as of March 2026
Overview
Attention Deficit Hyperactivity Disorder (ADHD) presents one of the more nuanced certification challenges in aviation medicine. The FAA's position is that a diagnosis of ADHD is not automatically disqualifying — but the stimulant medications commonly used to treat it (methylphenidate/Ritalin, amphetamine salts/Adderall, lisdexamfetamine/Vyvanse) are categorically disqualifying with no exceptions. This creates a difficult situation for pilots who rely on medication to manage their symptoms. To obtain or maintain an FAA medical certificate, you must be off all stimulant medications.
For pilots with a history of ADHD who are not currently on medication, the FAA requires evidence that the condition does not impair your ability to safely perform pilot duties. The standard pathway involves a comprehensive neuropsychological evaluation that assesses attention, executive function, impulsivity, processing speed, and other cognitive domains relevant to aviation safety. This evaluation must be performed by a qualified neuropsychologist and must specifically address whether the pilot can safely perform aviation tasks without medication. The FAA provides specific testing guidance to the evaluating psychologist through its Aerospace Medical Disposition tables.
There is growing discussion in the aviation community and Congress about modernizing the FAA's approach to ADHD, particularly regarding non-stimulant treatments. Atomoxetine (Strattera), guanfacine (Intuniv), and other non-stimulant ADHD medications remain disqualifying as of March 2026, though advocacy groups continue to push for reconsideration. The FAA's ADHD policy has not undergone a significant revision since the early 2000s, and many in the aviation medical community believe an update is overdue. Until policy changes, the only path to certification with an ADHD history is to demonstrate adequate cognitive function without medication.
FAA Requirements
Document Checklist
Gather these documents before your AME appointment to avoid delays and deferrals.
- 1FAA Form 8500-8 (MedXPress) with full disclosure of ADHD diagnosis and any medication history
- 2Comprehensive neuropsychological evaluation report from a qualified neuropsychologist
- 3Treating physician or psychiatrist status letter documenting ADHD history and current status
- 4Complete medication history — all ADHD medications used, dates, dosages, and date of discontinuation
- 5Academic transcripts or performance records (may be requested to show functional capacity)
- 6Prior psychological or psychiatric evaluation reports
- 7Any relevant school-based or workplace accommodation records
- 8Personal statement describing how you manage ADHD symptoms without medication (if requested)
Related Medications
Use our medication checker to see the FAA status of each medication related to this condition.
Important Disclaimer
This guide provides FAA regulatory information for educational purposes only. It does not constitute medical advice, legal advice, or a guarantee of certification outcome. FAA policies are subject to change. Always consult with a qualified Aviation Medical Examiner (AME) and/or aviation attorney for guidance specific to your individual situation. ClearedMed is not affiliated with or endorsed by the FAA.